J.ophthalmol.(Ukraine).2018;6:65-70.

http://doi.org/10.31288/oftalmolzh201866570

Received: 25 October  2018; Published on-line: 31 December 2018


Acute vision loss in neurosurgical and neurological disorders

V.A. Vasyuta, Dr Sc (Med); V.V. Biloshytskyi, Dr Sc (Med)

Romodanov Neurosurgery Institute, National Academy of Medical Science of Ukraine; 

Kyiv (Ukraine)

E-mail:  Vasyuta.v@ukr.net

TO CITE THIS ARTICLE: Vasyuta VA, Biloshytskyi VV. Acute vision loss in neurosurgical and neurological disorders. J.ophthalmol.(Ukraine).2018;6:65-70. http://doi.org/10.31288/oftalmolzh201866570 

 

The evaluation and management of acute vision loss is a multidisciplinary problem. Aneurysmal rupture producing a subarachnoid hemorrhage, craniocerebral injury, internal carotid artery disease, migraines (including ophthalmic and retinal ones), and lesions in the chiasmal and sellar regions, intracranial hypertension and demyelinating disorders are common neurosurgical and neurological causes of this condition. Neuro-ophthalmological manifestations include retinal hemorrhage and vascular occlusion, ischemic, traumatic and compressive neuropathy, neuritis and papilledema. Early detection and adequate assessment of neuro-ophthalmological symptoms are of primary importance.

Keywords: vision, acute loss, neurosurgical causes,    neuro-ophthalmological manifestations, detection

 

References

1.Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Jul;45(7):2160-236. doi: 10.1161/STR.0000000000000024.
Crossref   Pubmed

2.Rowe FJ, Wright D, Brand D, et al. A prospective profile of visual field loss following stroke: prevalence, type, rehabilitation, and outcome. Biomed Res Int. 2013; 2013: 719096. doi:  [10.1155/2013/719096].
Crossref   Pubmed

3.Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond). 2013 Jun;27(6):688-97. doi: 10.1038/eye.2013.25.
Crossref   Pubmed

4.Lamirel C, Newman NJ, Biousse V. Vascular Neuro-ophthalmology. Neurol Clin. 2010 Aug;28(3):701-27. doi: 10.1016/j.ncl.2010.03.009.
Crossref   Pubmed

5.Biousse V, Trobe JD. Transient monocular visual loss. Am J Ophthalmol. 2005 Oct;140(4):717-21. 
Crossref   Pubmed

6.Fisher CM. Transient monocular blindness versus amaurosis fugax. Neurology. 1989 Dec;39(12):1622-4.
Crossref   Pubmed

7.Luneak K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist. 2008 Nov;14(6):341-54. doi: 10.1097/NRL.0b013e318177394b.
Crossref   Pubmed

8.Hayer SS, Podhajsky PA, Zimmerman MS. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology. 2009 Oct;116(10):1928-36. doi: 10.1016/j.ophtha.2009.03.006.

9.Hayer SS, Zimmerman MB. Fundus changes in central retinal artery occlusion. Retina. 2007 Mar;27(3):276-89.

10.Fiess A, Cal O, Kehrein S, Halstenberg S, Frisch I, Steinhorst UH. Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy? BMC Ophthalmol. 2014 Mar 10;14:28. doi: 10.1186/1471-2415-14-28.

11.Rudkin AK, Lee AW, Aldrich E, et al. Clinical characteristics and outcome of current standard management of central retinal artery occlusion. Clin Exp Ophthalmol. 2010 Jul;38(5):496-501. doi: 10.1111/j.1442-9071.2010.02280.x.

12.Biousse V. Thrombolysis for acute central retinal artery occlusion: is it time? Am J Ophthalmol. 2008 Nov;146(5):631–4. doi: 10.1016/j.ajo.2008.07.025.

13.Page PS, Khattor NK, White AC, et al. Intra-arterial thrombolysis for acute central retinal artery occlusion: a systemic review and meta-analysis. Front Neurol. 2018 Feb 21;9:76. doi: 10.3389/fneur.2018.00076.

14.Biousse V, Newman NJ. Eye syndromes and the neuro-ophthalmology of stroke. Handb Clin Neurol. 2009;93:595-611. doi: 10.1016/S0072-9752(08)93029-3.

15.Pula JH, Yuen CA. Eyes and stroke: the visual aspects of cerebrovascular disease. Stroke Vasc Neurol. 017 Jul 6;2(4):210-220. doi: 10.1136/svn-2017-000079.

16.Klein R, Klein BE, Jensen SC, et al. Retinal emboli and stroke: the Beaver Dam Eye Study. Arch Ophthalmol. 1999 Aug;117(8):1063-8.

17.Mohamed Q, McIntosh RL, Saw SM, et al. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007 Mar;114(3):507-19, 524.

18.Shelton JB, Digre KB, Katz BJ, Warner JE, Quigley EP. Chiasmal stroke in patient with atrial fibrillation and complete occlusion of right internal carotid artery. J Neuroophthalmol. 2012 Jun;32(2):189. doi: 10.1097/WNO.0b013e3182491743.

19.Devuyst G, Bogousslavsky J, Meuli R, et al. Stroke or transient ischemic attacks with basilar artery stenosis or occlusion: clinical patterns and outcome. Arch Neurol. 2002 Apr;59(4):567-73.

20.Lauda F, Neugebauer H, Reiber L, et al. Acute silent brain infarction in Monocular Visual loss of ischemic origin. Cerebrovasc Dis. 2015;40(3-4):151-6. doi: 10.1159/000437274.

21.Glisson CC. Visual loss due to optic chiasm and retrochiasmal visual pathway lesions. Continuum (Minneap Minn). 2014 Aug;20(4 Neuro-ophthalmology):907-21. doi: 10.1212/01.CON.0000453312.37143.d2.

22.Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005 Apr;45 Suppl 1:S3-S13.

23.Evans RW, Glosberg BM. Retinal migraine: migraine associated with monocular visual symptoms. Headache. 2008 Jan;48(1):142-5. doi: 10.1111/j.1526-4610.2007.00978.x.

24.Gloster BM, Solomon S, Friedman DI, Lipton RB. Retinal migraine reappraised. Cephalalgia. 2006 Nov;26(11):1275-86.

25.Pradhan S, Chung SM. Retinal, ophthalmic or ocular migraine. Curr Neurol Neurosci Rep. 2004 Sep;4(5):391-7.

26.Rodriguez-Catarino M, Frisen L, Wikholm G, et al. Internal carotid artery aneurysms, cranial nerve dysfunction and headache: the role of deformation and pulsation. Neuroradiology. 2003 Apr;45(4):236-40. 

27.Biousse V, Newman NJ. Aneurysms and subarachnoid hemorrhage.  Neurosurg Clin North Am. 1999 Oct;10(4):631-51.

28.Schmidt GW, Oster SF, Golnik KC, Tumialán LM, Biousse V, Turbin R, Prestigiacomo CJ, Miller NR. Isolated progressive visual loss after coiling of paraclinoid aneurysms. AJNR Am J Neuroradiol. 2007 Nov-Dec;28(10):1882-9.

29.Astorga-Corballo A, Serna-Ojeda JC, Camargo-Suarez MF. Chiasmal syndrome: clinical characteristics in patients attending an ophthalmological center. Saudi J Ophthalmol. 2007 Oсt-Dec; 31(4): 229–33. doi: 10.1016/j.sjopt.2017.08.004.

30.Wadud SA, Ahmed S, Choudhury N, Chowdhury D. Evaluation of ophthalmic manifestations in patients with intracranial tumours. Mymensingh Med J. 2014 Apr;23(2):268-71.

31.Sefi-Yardakul N. Visual findings as primary manifestations in patients with intracranial tumors. Int J Ophthalmol. 2015 Aug 18;8(4):800-3. doi: 10.3980/j.issn.2222-3959.2015.04.28.

32.Ogra S, Nichols AD, Stylli S, Kaye AH, Savino PJ, Danesh-Meyer HV. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma. J Clin Neurosci. 2014 May;21(5):735-40. doi: 10.1016/j.jocn.2014.01.005.

33.Hayhurst C, Teo C. Tuberculum sella meningioma. Otolaryngol Clin North Am. 2011 Aug;44(4):953-63, viii-ix. doi: 10.1016/j.otc.2011.06.012.

34.Mahmoud M, Nader R, Al-Mefty O. Optic canal involvement in tuberculum sellae meningiomas: influence on approach, recurrence, and visual recovery. Neurosurgery. 2010 Sep;67(3 Suppl Operative):ons108-18; discussion ons118-9. doi: 10.1227/01.NEU.0000383153.75695.24.

35.Moon CH, Hwang SC, Kim BT, Ohn YH, Park TK. Visual prognostic value of optical coherence tomography and photopic negative response in chiasmal compression. Invest Ophthalmol Vis Sci. 2011 Oct 31;52(11):8527-33. doi: 10.1167/iovs.11-8034.

36.Monteiro ML, Costa-Cunha LV, Cunha LP, Malta RF. Correlation between macular and retinal nerve fibre layer Fourier-domain OCT measurements and visual field loss in chiasmal compression. Eye (Lond). 2010 Aug;24(8):1382-90. doi: 10.1038/eye.2010.48.

37.Anderson D, Khalil MK. Meningioma and the ophthalmologist: diagnostic pitfalls. Can J Ophthalmol. 1981 Jan;16(1):10–5.

38.Lee AG, Lin DJ, Kaufman M, Golnik KC, Vaphiades MS, Eggenberger E. Atypical features prompting neuroimaging in acute optic neuropathy in adults. Can J Ophthalmol. 2000 Oct;35(6):325-30.

39.Rigi M, Almarzouqi SJ, Morgan ML, Lee AG. Papilledema: epidemiology, etiology, and clinical management. Eye Brain. 2015 Aug 17;7:47-57. doi: 10.2147/EB.S69174.

40.Hathiram BT, Khattar VS, Sonawane HP, Watve PJ. Traumatic optic neuropathy - our experience.  Indian J Otolaryngol Head Neck Surg. 2010 Sep;62(3):229-35. doi: 10.1007/s12070-010-0072-y.

41.Chen YJ, Liang CM, Tai MC, et al. Longitudinal relationship between traumatic brain injury and the risk of incident optic neuropathy: A 10-year follow-up nationally representative Taiwan survey. Oncotarget. 2017 Sep 18;8(49):86924-86933. doi: 10.18632/oncotarget.21008.

42.Biousse V, Newman NJ. Diagnosis and clinical features of common optic neuropathies. Lancet Neurol. 2016 Dec;15(13):1355-1367. doi: 10.1016/S1474-4422(16)30237-X.

43.Roth S. Postoperative blindness, Anesthesia. 6th edition. Miller RD, ed. New York: Elsevier. 2015:2821–41.

44.Postoperative Visual Loss Study Group. Risk factors associated with ischemic optic neuropathy after spinal fusion surgery. Anesthesiology. 2012 Jan;116(1):15-24. doi: 10.1097/ALN.0b013e31823d012a. 

45.Roth S. Perioperative visual loss: what do we know, what can we do? Br J Anaesth. 2009 Dec;103 Suppl 1:i31-40. doi: 10.1093/bja/aep295.

46.Kupersmith MJ, Berenstein A, Flamm E, et al. Neuroophthalmologic abnormalities and intravascular therapy of traumatic carotid cavernous fistulas. Ophthalmology. 1986 Jul;93(7):906-12.

47.Miller N. Carotid-Cavernous Sinus Fistulas. In: Miller N, Newman N, Biousse B, Kerrison J, editors. Walsh & Hoyt’s Clinical Neuro-Ophthalmology. 6. Philadelphia: Williams & Wilkins; 2005. pp. 1967–2168.

48.Chai Y, Yamazaki H, Kondo A, Oshitari T, Yamamoto S. Case of acute optic nerve compression caused by tuberculum sellae meningioma with optic canal involvement. Clin Ophthalmol. 2012;6:661-6. doi: 10.2147/OPTH.S30418.